Cargando…

Impact of Gene Dosage on Gene Expression, Biological Processes and Survival in Cervical Cancer: A Genome-Wide Follow-Up Study

We investigated the role of tumor copy number (CN)–altered genome (CN-AG) in the carcinogenesis of cervical cancer (CC), especially its effect on gene expression, biological processes, and patient survival. Fifty-nine human papillomavirus 16 (HPV16)-positive CCs were investigated with microarrays–31...

Descripción completa

Detalles Bibliográficos
Autores principales: Medina-Martinez, Ingrid, Barrón, Valeria, Roman-Bassaure, Edgar, Juárez-Torres, Eligia, Guardado-Estrada, Mariano, Espinosa, Ana María, Bermudez, Miriam, Fernández, Fernando, Venegas-Vega, Carlos, Orozco, Lorena, Zenteno, Edgar, Kofman, Susana, Berumen, Jaime
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4039463/
https://www.ncbi.nlm.nih.gov/pubmed/24879114
http://dx.doi.org/10.1371/journal.pone.0097842
_version_ 1782318491105230848
author Medina-Martinez, Ingrid
Barrón, Valeria
Roman-Bassaure, Edgar
Juárez-Torres, Eligia
Guardado-Estrada, Mariano
Espinosa, Ana María
Bermudez, Miriam
Fernández, Fernando
Venegas-Vega, Carlos
Orozco, Lorena
Zenteno, Edgar
Kofman, Susana
Berumen, Jaime
author_facet Medina-Martinez, Ingrid
Barrón, Valeria
Roman-Bassaure, Edgar
Juárez-Torres, Eligia
Guardado-Estrada, Mariano
Espinosa, Ana María
Bermudez, Miriam
Fernández, Fernando
Venegas-Vega, Carlos
Orozco, Lorena
Zenteno, Edgar
Kofman, Susana
Berumen, Jaime
author_sort Medina-Martinez, Ingrid
collection PubMed
description We investigated the role of tumor copy number (CN)–altered genome (CN-AG) in the carcinogenesis of cervical cancer (CC), especially its effect on gene expression, biological processes, and patient survival. Fifty-nine human papillomavirus 16 (HPV16)-positive CCs were investigated with microarrays–31 for mapping CN-AG and 55 for global gene expression, with 27 CCs in common. Five-year survival was investigated in 55 patients. Deletions and amplifications >2.5 Mb were defined as CN alterations. The %CN-AG varied from 0 to 32.2% (mean = 8.1±8.9). Tumors were classified as low (mean = 0.5±0.6, n = 11), medium (mean = 5.4±2.4, n = 10), or high (mean = 19.2±6.6, n = 10) CN. The highest %CN-AG was found in 3q, which contributed an average of 55% of all CN alterations. Genome-wide, only 5.3% of CN-altered genes were deregulated directly by gene dosage. In contrast, the rate in fully duplicated 3q was twice as high. Amplification of 3q explained 23.2% of deregulated genes in whole tumors (r(2) = 0.232, p = 0.006; analysis of variance), including genes located in 3q and other chromosomes. A total of 862 genes were deregulated exclusively in high-CN tumors, but only 22.9% were CN altered. This suggests that the remaining genes are not deregulated directly by gene dosage, but by mechanisms induced in trans by CN-altered genes. Anaphase-promoting complex/cyclosome (APC/C)-dependent proteasome proteolysis, glycolysis, and apoptosis were upregulated, whereas cell adhesion and angiogenesis were downregulated exclusively in high-CN tumors. The high %CN-AG and upregulated gene expression profile of APC/C-dependent proteasome proteolysis were associated with poor patient survival (p<0.05, log-rank test). Along with glycolysis, they were linearly associated with FIGO stage (r>0.38, p<0.01, Spearman test). Therefore, inhibition of APC/C-dependent proteasome proteolysis and glycolysis could be useful for CC treatment. However, whether they are indispensable for tumor growth remains to be demonstrated.
format Online
Article
Text
id pubmed-4039463
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-40394632014-06-02 Impact of Gene Dosage on Gene Expression, Biological Processes and Survival in Cervical Cancer: A Genome-Wide Follow-Up Study Medina-Martinez, Ingrid Barrón, Valeria Roman-Bassaure, Edgar Juárez-Torres, Eligia Guardado-Estrada, Mariano Espinosa, Ana María Bermudez, Miriam Fernández, Fernando Venegas-Vega, Carlos Orozco, Lorena Zenteno, Edgar Kofman, Susana Berumen, Jaime PLoS One Research Article We investigated the role of tumor copy number (CN)–altered genome (CN-AG) in the carcinogenesis of cervical cancer (CC), especially its effect on gene expression, biological processes, and patient survival. Fifty-nine human papillomavirus 16 (HPV16)-positive CCs were investigated with microarrays–31 for mapping CN-AG and 55 for global gene expression, with 27 CCs in common. Five-year survival was investigated in 55 patients. Deletions and amplifications >2.5 Mb were defined as CN alterations. The %CN-AG varied from 0 to 32.2% (mean = 8.1±8.9). Tumors were classified as low (mean = 0.5±0.6, n = 11), medium (mean = 5.4±2.4, n = 10), or high (mean = 19.2±6.6, n = 10) CN. The highest %CN-AG was found in 3q, which contributed an average of 55% of all CN alterations. Genome-wide, only 5.3% of CN-altered genes were deregulated directly by gene dosage. In contrast, the rate in fully duplicated 3q was twice as high. Amplification of 3q explained 23.2% of deregulated genes in whole tumors (r(2) = 0.232, p = 0.006; analysis of variance), including genes located in 3q and other chromosomes. A total of 862 genes were deregulated exclusively in high-CN tumors, but only 22.9% were CN altered. This suggests that the remaining genes are not deregulated directly by gene dosage, but by mechanisms induced in trans by CN-altered genes. Anaphase-promoting complex/cyclosome (APC/C)-dependent proteasome proteolysis, glycolysis, and apoptosis were upregulated, whereas cell adhesion and angiogenesis were downregulated exclusively in high-CN tumors. The high %CN-AG and upregulated gene expression profile of APC/C-dependent proteasome proteolysis were associated with poor patient survival (p<0.05, log-rank test). Along with glycolysis, they were linearly associated with FIGO stage (r>0.38, p<0.01, Spearman test). Therefore, inhibition of APC/C-dependent proteasome proteolysis and glycolysis could be useful for CC treatment. However, whether they are indispensable for tumor growth remains to be demonstrated. Public Library of Science 2014-05-30 /pmc/articles/PMC4039463/ /pubmed/24879114 http://dx.doi.org/10.1371/journal.pone.0097842 Text en © 2014 Medina-Martínez et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Medina-Martinez, Ingrid
Barrón, Valeria
Roman-Bassaure, Edgar
Juárez-Torres, Eligia
Guardado-Estrada, Mariano
Espinosa, Ana María
Bermudez, Miriam
Fernández, Fernando
Venegas-Vega, Carlos
Orozco, Lorena
Zenteno, Edgar
Kofman, Susana
Berumen, Jaime
Impact of Gene Dosage on Gene Expression, Biological Processes and Survival in Cervical Cancer: A Genome-Wide Follow-Up Study
title Impact of Gene Dosage on Gene Expression, Biological Processes and Survival in Cervical Cancer: A Genome-Wide Follow-Up Study
title_full Impact of Gene Dosage on Gene Expression, Biological Processes and Survival in Cervical Cancer: A Genome-Wide Follow-Up Study
title_fullStr Impact of Gene Dosage on Gene Expression, Biological Processes and Survival in Cervical Cancer: A Genome-Wide Follow-Up Study
title_full_unstemmed Impact of Gene Dosage on Gene Expression, Biological Processes and Survival in Cervical Cancer: A Genome-Wide Follow-Up Study
title_short Impact of Gene Dosage on Gene Expression, Biological Processes and Survival in Cervical Cancer: A Genome-Wide Follow-Up Study
title_sort impact of gene dosage on gene expression, biological processes and survival in cervical cancer: a genome-wide follow-up study
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4039463/
https://www.ncbi.nlm.nih.gov/pubmed/24879114
http://dx.doi.org/10.1371/journal.pone.0097842
work_keys_str_mv AT medinamartinezingrid impactofgenedosageongeneexpressionbiologicalprocessesandsurvivalincervicalcanceragenomewidefollowupstudy
AT barronvaleria impactofgenedosageongeneexpressionbiologicalprocessesandsurvivalincervicalcanceragenomewidefollowupstudy
AT romanbassaureedgar impactofgenedosageongeneexpressionbiologicalprocessesandsurvivalincervicalcanceragenomewidefollowupstudy
AT juareztorreseligia impactofgenedosageongeneexpressionbiologicalprocessesandsurvivalincervicalcanceragenomewidefollowupstudy
AT guardadoestradamariano impactofgenedosageongeneexpressionbiologicalprocessesandsurvivalincervicalcanceragenomewidefollowupstudy
AT espinosaanamaria impactofgenedosageongeneexpressionbiologicalprocessesandsurvivalincervicalcanceragenomewidefollowupstudy
AT bermudezmiriam impactofgenedosageongeneexpressionbiologicalprocessesandsurvivalincervicalcanceragenomewidefollowupstudy
AT fernandezfernando impactofgenedosageongeneexpressionbiologicalprocessesandsurvivalincervicalcanceragenomewidefollowupstudy
AT venegasvegacarlos impactofgenedosageongeneexpressionbiologicalprocessesandsurvivalincervicalcanceragenomewidefollowupstudy
AT orozcolorena impactofgenedosageongeneexpressionbiologicalprocessesandsurvivalincervicalcanceragenomewidefollowupstudy
AT zentenoedgar impactofgenedosageongeneexpressionbiologicalprocessesandsurvivalincervicalcanceragenomewidefollowupstudy
AT kofmansusana impactofgenedosageongeneexpressionbiologicalprocessesandsurvivalincervicalcanceragenomewidefollowupstudy
AT berumenjaime impactofgenedosageongeneexpressionbiologicalprocessesandsurvivalincervicalcanceragenomewidefollowupstudy